πŸ‡ΊπŸ‡Έ FDA
Patent

US 10556892

Piperazinyl methanone NAAA inhibitors

granted A61PA61P25/16A61P25/28

Quick answer

US patent 10556892 (Piperazinyl methanone NAAA inhibitors) held by The Regents of the University of California expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P25/16, A61P25/28